亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Abstract LB291: Monitoring and targeting therapy resistance mediating neuroendocrine trans-differentiation in breast cancer via the neurod1/ncam axis

作者
Roberto Würth,Tasneem Cheytan,Paul Schwerd‐Kleine,Ewgenija Gutjahr,Martin Ronald Sprick,Andreas Trumpp
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:85 (8_Supplement_2): LB291-LB291 被引量:1
标识
DOI:10.1158/1538-7445.am2025-lb291
摘要

Abstract Neuroendocrine breast carcinoma (NEBC) is a rare, aggressive subtype of breast cancer known for its high resistance to therapies. Unlike prostate, pulmonary, or gastroenteropancreatic tumors where neuroendocrine trans-differentiation (NED) is recognized as a key driver of intra-tumoral heterogeneity and treatment resistance, NEBC remain poorly characterized. Its rarity, combined with its emergence predominantly as a relapse-associated therapy escape mechanism, presents significant challenges for research and clinical management. Neuroendocrine transdifferentiation underscores the remarkable plasticity of cancer cells under therapeutic pressure. The absence of robust patient-derived NEBC models further hampers progress in understanding this resistant state and developing effective interventions. In addition, beyond synaptophysin detection through histopathological analysis, there are limited actionable biomarkers to clinically detect or monitor NEBC appearance post-treatment.To investigate neuroendocrine-mediated resistance, we leveraged our recently developed Circulating Tumor Cell (CTC)-organoid platform and established unique patient-derived organoid (PDO) models that faithfully mirror the key features of NEBC, including its intra-tumoral heterogeneity and multidrug resistance. Through comparative analysis of matched epithelial and neuroendocrine PDOs derived from distinct sites of the same patient tumor, we uncovered distinct molecular and genetic profiles that offer valuable insights into NEBC biology and resistance mechanisms. While both cell types shared some genetic alterations (e.g., ERBB2 and MYCN amplification, TP53 loss), NEBC cells exhibited unique additional genomic rearrangements and downregulated ERBB2 expression. Multi-omics data integration allowed us to identify the transcription factor NEUROD1 as a key driver of neuroendocrine reprogramming. Moreover, our findings indicate that the NEUROD1 downstream target neural cell adhesion molecule (NCAM) serves as a potential biomarker for stratifying NEBC patients, detectable through NCAM-expressing CTCs in liquid biopsies. Additionally, a comprehensive drug screen revealed that NEBC cells are particularly sensitive to CDK4/6 and FGFR inhibitors. Collectively, by integrating NCAM expression on circulating CTCs analysis, we introduce a novel diagnostic tool possibly enabling early and longitudinal detection of treatment resistant NED cells. Our preclinical data also identified promising novel therapeutic avenues, such as CDK4/6 inhibition, which should be further explored for the management of the complex disease state of neuroendocrine breast cancer.1 Würth, R., et al. Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signaling (2025). Nature Cancer, Jan 3. doi: 10.1038/s43018-024-00882-2 Citation Format: Roberto Würth, Tasneem Cheytan, Paul Schwerd-Kleine, Ewgenija Gutjahr, Martin Sprick, Andreas Trumpp. Monitoring and targeting therapy resistance mediating neuroendocrine trans-differentiation in breast cancer via the neurod1/ncam axis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_2):Abstract nr LB291.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wsdow完成签到,获得积分10
2秒前
兴奋的疾完成签到,获得积分10
5秒前
852的应助被ahworld采纳,获得10
9秒前
迷人悒完成签到,获得积分10
22秒前
虚拟的元正完成签到,获得积分10
23秒前
yyy完成签到 ,获得积分10
28秒前
ding的应助被ahworld采纳,获得10
28秒前
fantasy的应助被科研通管家采纳,获得10
33秒前
null的应助被科研通管家采纳,获得10
33秒前
34秒前
37秒前
淡淡的怜翠完成签到,获得积分10
42秒前
44秒前
ni完成签到 ,获得积分10
45秒前
ahworld发布了新的文献求助10
49秒前
温不胜的破木吉他完成签到 ,获得积分10
58秒前
安可完成签到,获得积分20
1分钟前
希望天下0贩的0的应助被安可采纳,获得10
1分钟前
深情豁完成签到,获得积分10
1分钟前
温柔的香岚完成签到,获得积分10
1分钟前
A2QD发布了新的文献求助10
1分钟前
claire完成签到 ,获得积分10
1分钟前
1分钟前
安可发布了新的文献求助10
1分钟前
寒冷的月亮完成签到 ,获得积分10
1分钟前
Nori完成签到 ,获得积分10
1分钟前
土豪的剑身完成签到,获得积分10
2分钟前
脑洞疼的应助被A2QD采纳,获得10
2分钟前
孙菜炖粉条完成签到 ,获得积分10
2分钟前
奔跑的应助被Alice采纳,获得10
2分钟前
独特珩完成签到,获得积分10
2分钟前
明亮的藏鸟完成签到,获得积分10
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
酷波er的应助被科研通管家采纳,获得10
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
automan完成签到,获得积分10
2分钟前
2分钟前
parantal发布了新的文献求助10
2分钟前
灵剑山发布了新的文献求助10
2分钟前
冷傲的妙竹完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173069
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780383
捐赠科研通 7765085
什么是DOI,文献DOI怎么找? 3431528
关于科研通互助平台的介绍 2555638
邀请新用户注册赠送积分活动 2476668